BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15946993)

  • 1. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
    Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
    FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling.
    Bae S; Zhang L
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1125-35. PubMed ID: 16099927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling.
    Zheng Z; Yang M; Zhang F; Yu J; Wang J; Ma L; Zhong Y; Qian L; Chen G; Yu L; Yan M
    J Surg Res; 2011 Sep; 170(1):e3-9. PubMed ID: 21704330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.
    Penna C; Alloatti G; Cappello S; Gattullo D; Berta G; Mognetti B; Losano G; Pagliaro P
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2512-20. PubMed ID: 15637120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
    Mozaffari MS; Liu JY; Schaffer SW
    Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase - Akt pathway.
    Zhang JY; Chen ZW; Yao H
    Can J Physiol Pharmacol; 2012 May; 90(5):637-45. PubMed ID: 22537485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.
    Cai Z; Semenza GL
    Circulation; 2004 May; 109(17):2050-3. PubMed ID: 15117842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.
    Philipp S; Yang XM; Cui L; Davis AM; Downey JM; Cohen MV
    Cardiovasc Res; 2006 May; 70(2):308-14. PubMed ID: 16545350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.
    Tsang A; Hausenloy DJ; Mocanu MM; Yellon DM
    Circ Res; 2004 Aug; 95(3):230-2. PubMed ID: 15242972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.
    Padua RR; Merle PL; Doble BW; Yu CH; Zahradka P; Pierce GN; Panagia V; Kardami E
    J Mol Cell Cardiol; 1998 Dec; 30(12):2695-709. PubMed ID: 9990540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
    Bullard AJ; Govewalla P; Yellon DM
    Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.